|
Almanchel-Rivadeneyra M, Alonso Romero JL, Tomas-Luiz A, Diaz Carrasco MS. Drug-drug interactions in adjuvant and neoadjuvant breast cancer therapy. Eur J Hosp Pharm. 2026 Jan 6:ejhpharm-2025-004761. doi: 10.1136/ejhpharm-2025-004761. Online ahead of print. PubMed PMID: 41494827.
AÑO: 2026; IF: 1.5
|
41494827
|
Alonso-Romero JL, Martinez-Garcia J, Carrillo-Vicente R, Aramburo AF, Diez AF, Henarejos PS, de la Morena Barrio P, Boix AP, Jimenez MD, Siles JP, Maestre JAP, de Las Heras-Rubio A, Carreno PR. Translational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer. Breast Cancer Res Treat. 2026 Jan 20;215(2):60. doi: 10.1007/s10549-026-07895-8. PubMed PMID: 41557021; PubMed Central PMCID: PMC12819485.
AÑO: 2026; IF: 3.0
|
|
Encarnacion JA, Lopez-Jimenez E, Alonso-Romero JL, Ruiz P, Ros S, De la Fuente MI, Lopez F, Cardenas E, Laborda A, Sanchez-Perez M, Rodriguez C, Manso C, Ortega-Lopez ND, Lopez-Cubillana P, Guzman Martinez-Valls PL, Cao-Avellaneda E, Lopez-Gonzalez PA, Lopez-Abad A. Bone Health in Metastatic Hormone-Sensitive Prostate Cancer: Where We Stand and Where We Can Improve. Cancers (Basel). 2025 Dec 13;17(24):3977. doi: 10.3390/cancers17243977. PubMed PMID: 41463226; PubMed Central PMCID: PMC12730855.
AÑO: 2025; IF: 4.4
|
|
Encarnacion JA, Ibanez N, De la Fuente I, Ruiz P, Gonzalez S, Quiles B, Sanchez M, Bautista Y, Rodriguez C, Nadal JA, Marin M, Marin-Zafra G, Guirao M, Hernandez Q, Abrisqueta J, Abellan I, Montoya M, Ono A, Carbonell G, Frutos L, Ortiz E, Manso C, Royo-Villanova M, Alonso-Romero JL. Clinical Complete Response and Organ Preservation Strategies in Rectal Cancer: A Real-World Single-Center Experience Clinical Complete Response and Organ Preservation in Rectal Cancer. Cancers (Basel). 2026 Feb 27;18(5):763. doi: 10.3390/cancers18050763. PubMed PMID: 41827698; PubMed Central PMCID: PMC12985280.
AÑO: 2026; IF: 4.4
|